Phase 4 HCC Clinical Trials
7 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–7 of 7 trials
Recruiting
Phase 4
HOPE Against Cancer Recurrence in HCC
HCCLiver TransplantationOncological Outcomes
Philipp Dutkowski220 enrolled37 locationsNCT06717919
Recruiting
Phase 4
The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine
Hepatocellular Carcinoma (HCC)Liver Diseases
Anhui Provincial Hospital96 enrolled1 locationNCT07150624
Recruiting
Phase 4
Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
CirrhosisHCC - Hepatocellular CarcinomaPortal Vein Thrombosis
Mansoura University100 enrolled1 locationNCT07132515
Recruiting
Phase 4
A Study of AK112, a PD-1/ VEGF Bispecific Antibody, for Resectable Hepatocellular Carcinoma With High Recurrence Risk
HCC
The First Affiliated Hospital of Zhengzhou University30 enrolled1 locationNCT06930573
Recruiting
Phase 4
Endoscopic Variceal Ligation vs Carvedilol for the Prevention of First Esophageal Variceal Bleeding in Patients With HCC
Hepatocellular Carcinoma (HCC)Esophageal Varices
Taipei Veterans General Hospital, Taiwan120 enrolled1 locationNCT06594744
Recruiting
Phase 4
Triple vs. Dual Adjuvant Therapy Following Liver Resection for HCC.
HCC
Chen Xiaoping300 enrolled1 locationNCT06311942
Recruiting
Phase 4
Precision Adjuvant Therapy After Surgery for Hepatocellular Carcinoma
HCC
Chen Xiaoping300 enrolled1 locationNCT06311929